Welcome to our dedicated page for Ashland news (Ticker: ASH), a resource for investors and traders seeking the latest updates and insights on Ashland stock.
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company serving markets such as architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. The ASH news feed on Stock Titan brings together company announcements, earnings releases and operational updates that reflect how this specialty materials business is performing and evolving across its segments.
Investors following ASH news can review detailed quarterly and annual earnings releases, where Ashland discusses sales, segment performance in Life Sciences, Personal Care, Specialty Additives and Intermediates, and the impact of portfolio optimization and manufacturing network initiatives. These releases often describe demand trends in pharmaceuticals, personal care, coatings and intermediates, along with commentary on pricing, volumes and regional dynamics.
News items also include capital allocation updates such as quarterly cash dividend declarations on Ashland common stock and information about share repurchase activity referenced in proxy materials. Governance and leadership developments, including appointments or changes in senior management and board composition, are reported through press releases and related Form 8-K filings.
Operational updates can cover topics such as production network changes or incidents at manufacturing facilities, with Ashland explaining expected effects on operations, costs and customer deliveries. The company also uses news releases to communicate scheduling details for earnings conference call webcasts and to provide access information for investors and analysts.
By monitoring the ASH news page, readers can track how Ashland’s additives and specialty ingredients business responds to market conditions, executes its Execute, Globalize, Innovate and Invest strategy, and advances ESG and sustainability priorities described in its proxy statement and public communications.
Ashland Inc. (NYSE: ASH) appoints Ashish K. Kulkarni, CEO of Kebotix, to its Board of Directors. Kulkarni brings vast experience from leading companies, enhancing innovation, growth, and profitability. The Board expands to 11 members with his addition.
Ashland Inc. (ASH) board of directors has approved a quarterly dividend of $0.405 per share, marking a five percent increase from the prior quarter. The dividend will be paid on June 15, 2024, to stockholders on record as of June 1, 2024. As of April 30, 2024, there were 50,128,349 shares of Ashland common stock outstanding.
Turnspire Capital Partners has announced the acquisition of the nutraceuticals business of Ashland Inc. The acquisition includes Ashland Nutraceuticals, a leading provider of nutrition ingredients and custom formulation services for the nutrition market. Ashland Nutraceuticals has approximately 500 employees across four production facilities in the US and Mexico. The transaction is expected to be completed in the third quarter of 2024.
Ashland Inc. (NYSE: ASH) has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners The transaction is set to close in the third quarter of 2024. Ashland's nutraceuticals business offers active ingredients and formulation aids to nutritional product companies, alongside custom formulation and contract manufacturing services. The deal highlights the business's strong portfolio and capabilities.
Ashland Inc. (NYSE: ASH) reported financial results for the second quarter of fiscal year 2024, with sales at $575 million, down five percent from the prior-year quarter. Net income reached $120 million, or $2.39 per diluted share. Adjusted EBITDA was $126 million, and cash flows from operating activities were $54 million. The company's outlook for the third quarter and full-year fiscal 2024 shows an optimistic perspective on the demand normalization in key segments like Personal Care and Specialty Additives.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.